96 related articles for article (PubMed ID: 28587486)
21. Eudragit RS 100 microparticles containing 2-hydroxypropyl-beta-cyclodextrin and glutathione: physicochemical characterization, drug release and transport studies.
Trapani A; Laquintana V; Denora N; Lopedota A; Cutrignelli A; Franco M; Trapani G; Liso G
Eur J Pharm Sci; 2007 Jan; 30(1):64-74. PubMed ID: 17118631
[TBL] [Abstract][Full Text] [Related]
22. Formulation, characterization and in vitro evaluation of theophylline-loaded Eudragit RS 100 microspheres prepared by an emulsion-solvent diffusion/evaporation technique.
Jelvehgari M; Barar J; Valizadeh H; Shadrou S; Nokhodchi A
Pharm Dev Technol; 2011; 16(6):637-44. PubMed ID: 20722498
[TBL] [Abstract][Full Text] [Related]
23. Controlled Dissolution of Griseofulvin Solid Dispersions from Electrosprayed Enteric Polymer Micromatrix Particles: Physicochemical Characterization and in Vitro Evaluation.
Roine J; Kaasalainen M; Peurla M; Correia A; Araújo F; Santos HA; Murtomaa M; Salonen J
Mol Pharm; 2015 Jul; 12(7):2254-64. PubMed ID: 26035734
[TBL] [Abstract][Full Text] [Related]
24. Chronotherapeutic drug delivery of Tamarind gum, Chitosan and Okra gum controlled release colon targeted directly compressed Propranolol HCl matrix tablets and in-vitro evaluation.
Newton AM; Indana VL; Kumar J
Int J Biol Macromol; 2015 Aug; 79():290-9. PubMed ID: 25936283
[TBL] [Abstract][Full Text] [Related]
25. Drug-polymer intermolecular interactions in hot-melt extruded solid dispersions.
Maniruzzaman M; Morgan DJ; Mendham AP; Pang J; Snowden MJ; Douroumis D
Int J Pharm; 2013 Feb; 443(1-2):199-208. PubMed ID: 23262428
[TBL] [Abstract][Full Text] [Related]
26. Propranolol hydrochloride-anionic polymer binding interaction.
Takka S
Farmaco; 2003 Oct; 58(10):1051-6. PubMed ID: 14505738
[TBL] [Abstract][Full Text] [Related]
27. Preparation and in vitro evaluation of modified release ketoprofen microsponges.
Comoğlu T; Gönül N; Baykara T
Farmaco; 2003 Feb; 58(2):101-6. PubMed ID: 12581775
[TBL] [Abstract][Full Text] [Related]
28. Electrosprayed Nanoparticles Containing Hydroalcoholic Extract of
Mehdizadeh F; Mohammadzadeh R; Nazemiyeh H; Mesgari-Abbasi M; Barzegar-Jalali M; Eskandani M; Adibkia K
Adv Pharm Bull; 2023 Mar; 13(2):283-289. PubMed ID: 37342366
[No Abstract] [Full Text] [Related]
29. Mebeverine-loaded electrospun nanofibers: physicochemical characterization and dissolution studies.
Illangakoon UE; Nazir T; Williams GR; Chatterton NP
J Pharm Sci; 2014 Jan; 103(1):283-92. PubMed ID: 24258335
[TBL] [Abstract][Full Text] [Related]
30. Flurbiprofen release from Eudragit RS and RL aqueous nanosuspensions: a kinetic study by DSC and dialysis experiments.
Castelli F; Messina C; Sarpietro MG; Pignatello R; Puglisi G
AAPS PharmSciTech; 2002; 3(2):E9. PubMed ID: 12916946
[TBL] [Abstract][Full Text] [Related]
31. In vivo evaluation of modified gum karaya as a carrier for improving the oral bioavailability of a poorly water-soluble drug, nimodipine.
Murali Mohan Babu GV; Kumar NR; Sankar KH; Ram BJ; Kumar NK; Murthy KV
AAPS PharmSciTech; 2002; 3(2):E12. PubMed ID: 12916949
[TBL] [Abstract][Full Text] [Related]
32. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.
Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
Colloids Surf B Biointerfaces; 2010 Mar; 76(1):170-8. PubMed ID: 19945828
[TBL] [Abstract][Full Text] [Related]
33. Eudragit-based transdermal delivery system of pentazocine: Physico-chemical, in vitro and in vivo evaluations.
Chandak AR; Prasad Verma PR
Pharm Dev Technol; 2010 Jun; 15(3):296-304. PubMed ID: 22716470
[TBL] [Abstract][Full Text] [Related]
34. Self-assembly and controlled release behaviour of the water-insoluble drug nifedipine from electrospun PCL-based polyurethane nanofibres.
Lin X; Tang D; Du H
J Pharm Pharmacol; 2013 May; 65(5):673-81. PubMed ID: 23600384
[TBL] [Abstract][Full Text] [Related]
35. Novel microparticle drug delivery systems based on chitosan and Eudragit® RSPM to enhance diltiazem hydrochloride release property.
Cetin EO; Gundogdu E; Kirilmaz L
Pharm Dev Technol; 2012; 17(6):741-6. PubMed ID: 21563988
[TBL] [Abstract][Full Text] [Related]
36. Pharmacodynamics of diclofenac from novel Eudragit entrapped microspheres.
Momoh MA; Kenechukwu FC; Adedokun MO; Odo CE; Attama AA
Drug Deliv; 2014 May; 21(3):193-203. PubMed ID: 24171400
[TBL] [Abstract][Full Text] [Related]
37. An in-vitro-in-vivo taste assessment of bitter drug: comparative electronic tongues study.
Maniruzzaman M; Douroumis D
J Pharm Pharmacol; 2015 Jan; 67(1):43-55. PubMed ID: 25182780
[TBL] [Abstract][Full Text] [Related]
38. Electrosprayed Eudragit RL100 nanoparticles with Janus polyvinylpyrrolidone patches for multiphase release of paracetamol.
Zhou J; Pan H; Gong W; Yu DG; Sun Y
Nanoscale; 2024 May; 16(17):8573-8582. PubMed ID: 38602025
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles.
Dillen K; Vandervoort J; Van den Mooter G; Ludwig A
Int J Pharm; 2006 May; 314(1):72-82. PubMed ID: 16600538
[TBL] [Abstract][Full Text] [Related]
40. Organic solution versus aqueous dispersion of Eudragit RS in preparation of sustained release microparticles of theophylline using spray drying.
Garekani HA; Moghaddam ZF; Sadeghi F
Colloids Surf B Biointerfaces; 2013 Aug; 108():374-9. PubMed ID: 23602991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
